Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methemoglobinemia Following Intravenous Iron Treatment Administered as Ferric Carboxymaltose or Ferric Derisomaltose in Patients With Anemia

NCT06309641 is registered in ClinicalTrials.gov with Claudia Seiler as lead sponsor.

NCT NCT06309641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06309641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methemoglobinemia Following Intravenous Iron Treatment Administered as Ferric Carboxymaltose or Ferric Derisomaltose in Patients With Anemia
Lead sponsor
Claudia Seiler
Phase
Observational
Overall status
Completed
Start date
September 2, 2024
Completion date
October 13, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiencies, methemoglobinemia, side effect